🏥 治験ポータル
← 治験一覧に戻る

腸管外病原性大腸菌2型による侵襲性疾患に関する情報を収集するための研究(EXPECT-2)

基本情報

NCT ID
NCT04117113
ステータス
完了
試験のフェーズ
-
試験タイプ
観察
目標被験者数
238
治験依頼者名
UMC Utrecht

概要

The purpose of this study is to collect information from study participants who are hospitalized with an invasive disease caused by Extraintestinal pathogenic E. coli (ExPEC). This information will be used to support the development of a new vaccine to prevent Extraintestinal pathogenic Escherichia coli (ExPEC). E. coli bacteria are a leading cause of serious infections. Especially adults older than 60 years have a higher risk of developing such infections. To date, there is no vaccine available to prevent E. coli infections. To support the development of a vaccine, more information about E. coli infections is first needed. This information will be collected in the current study, such as: * Medical information such as medical history, diagnosis, duration of hospitalization * Treatment and outcome of the Extraintestinal pathogenic Escherichia coli (ExPEC) * Laboratory information

対象疾患

E. Coli Infection

実施施設 (1)

Janssen Pharmaceutical K.K.

Tokyo, Chiyoda-ku, Japan